LOXO ONCOLOGY INC's ticker is LOXO and the CUSIP is 548862101. A total of 49 filers reported holding LOXO ONCOLOGY INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $32,610,000 | -7.4% | 232,815 | +13.0% | 0.01% | +11.1% |
| Q3 2018 | $35,203,000 | -14.5% | 206,068 | -13.1% | 0.01% | -18.2% |
| Q2 2018 | $41,153,000 | +44.9% | 237,218 | -3.6% | 0.01% | +57.1% |
| Q1 2018 | $28,399,000 | +86.4% | 246,154 | +36.0% | 0.01% | +75.0% |
| Q4 2017 | $15,239,000 | -11.2% | 181,021 | -2.8% | 0.00% | 0.0% |
| Q3 2017 | $17,155,000 | +57.0% | 186,211 | +36.7% | 0.00% | +33.3% |
| Q2 2017 | $10,924,000 | +487.3% | 136,228 | +208.4% | 0.00% | +200.0% |
| Q1 2017 | $1,860,000 | +37.5% | 44,178 | +4.9% | 0.00% | – |
| Q4 2016 | $1,353,000 | +256.1% | 42,133 | +37.9% | 0.00% | – |
| Q1 2015 | $380,000 | +11.1% | 30,547 | +4.9% | 0.00% | – |
| Q4 2014 | $342,000 | -35.0% | 29,107 | -27.3% | 0.00% | – |
| Q3 2014 | $526,000 | – | 40,040 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital LLC | 2,038,920 | $285,592,000 | 80.87% |
| DAFNA Capital Management LLC | 181,675 | $25,447,000 | 12.65% |
| Opaleye Management Inc. | 175,000 | $24,512,000 | 9.15% |
| Casdin Capital, LLC | 360,000 | $50,425,000 | 8.63% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 21,775 | $3,050,000 | 3.58% |
| Avoro Capital Advisors LLC | 325,000 | $45,523,000 | 2.72% |
| AWM Investment Company, Inc. | 70,000 | $9,805,000 | 2.13% |
| Opus Point Partners Management, LLC | 6,210 | $870,000 | 1.92% |
| Eventide Asset Management | 274,000 | $38,379,000 | 1.70% |
| Aquilo Capital Management, LLC | 24,750 | $3,467,000 | 1.68% |